Literature DB >> 19968565

Parathyroid hormone regulates fetal-placental mineral homeostasis.

Charlene S Simmonds1, Gerard Karsenty, Andrew C Karaplis, Christopher S Kovacs.   

Abstract

Parathyroid hormone (PTH) plays an essential role in regulating calcium and bone homeostasis in the adult, but whether PTH is required at all for regulating fetal-placental mineral homeostasis and skeletal development is uncertain. We hypothesized that despite its low circulating levels during fetal life, PTH plays a critical role in regulating these processes. To address this, we examined two different genetic models of PTH deficiency. Pth null mice have enlarged parathyroids that are incapable of making PTH, whereas Gcm2 null mice lack parathyroids but have PTH that arises from the thymus. Pth nulls served as a model of complete absence of PTH, whereas Gcm2 nulls were a model of severe hypoparathyroidism. We determined that PTH contributes importantly to fetal mineral homeostasis because in its absence a fetal hypoparathyroid phenotype results with hypocalcemia, hypomagnesemia, hyperphosphatemia, low amniotic fluid mineral content, and reduced skeletal mineral content. We also determined that PTH is expressed in the placenta, regulates the placental expression of genes involved in calcium and other solute transfer, and may directly stimulate placental calcium transfer. Although parathyroid hormone-related protein (PTHrP) acts in concert with PTH to regulate fetal mineral homeostasis and placental calcium transfer, unlike PTH, it does not upregulate in response to fetal hypocalcemia. Copyright 2010 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19968565     DOI: 10.1359/jbmr.090825

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  21 in total

Review 1.  Bone development in the fetus and neonate: role of the calciotropic hormones.

Authors:  Christopher S Kovacs
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

2.  Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes.

Authors:  Jillian N Collins; Beth J Kirby; Janine P Woodrow; Robert F Gagel; Clifford J Rosen; Natalie A Sims; Christopher S Kovacs
Journal:  Endocrinology       Date:  2013-03-05       Impact factor: 4.736

3.  FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth.

Authors:  Yue Ma; Beth J Kirby; Nicholas A Fairbridge; Andrew C Karaplis; Beate Lanske; Christopher S Kovacs
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

Review 4.  Vitamin D in pregnancy: current perspectives and future directions.

Authors:  Mairead Kiely; Andrea Hemmingway; Karen M O'Callaghan
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-05-02       Impact factor: 5.346

5.  Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization.

Authors:  Yue Ma; Manoharee Samaraweera; Sandra Cooke-Hubley; Beth J Kirby; Andrew C Karaplis; Beate Lanske; Christopher S Kovacs
Journal:  Endocrinology       Date:  2014-03-06       Impact factor: 4.736

6.  Bone Is a Major Target of PTH/PTHrP Receptor Signaling in Regulation of Fetal Blood Calcium Homeostasis.

Authors:  Takao Hirai; Tatsuya Kobayashi; Shigeki Nishimori; Andrew C Karaplis; David Goltzman; Henry M Kronenberg
Journal:  Endocrinology       Date:  2015-06-08       Impact factor: 4.736

Review 7.  Bone metabolism in the fetus and neonate.

Authors:  Christopher S Kovacs
Journal:  Pediatr Nephrol       Date:  2013-03-26       Impact factor: 3.714

Review 8.  Parathyroid hormone-related protein: an update.

Authors:  John J Wysolmerski
Journal:  J Clin Endocrinol Metab       Date:  2012-06-28       Impact factor: 5.958

Review 9.  Hyperplasia in glands with hormone excess.

Authors:  Stephen J Marx
Journal:  Endocr Relat Cancer       Date:  2015-09-25       Impact factor: 5.678

10.  Generation of mice encoding a conditional null allele of Gcm2.

Authors:  Ziqiang Yuan; Evan E Opas; Chakravarthy Vrikshajanani; Steven K Libutti; Michael A Levine
Journal:  Transgenic Res       Date:  2014-04-16       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.